New study evaluates incidence and mortality of prostate cancer after termination of PSA-based screening
Monday, March 18, 2013 - 15:30
in Health & Medicine
Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study.